Congenital and acquired long QT syndrome
Population
Patients with or at risk for congenital or acquired long QT syndrome
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Clinicians should review QT-prolonging medications in vulnerable patients; leaves open refined risk stratification by genetics and comorbidities.
Structured PICO
P
Population
Patients with or at risk for congenital or acquired long QT syndrome
This review highlights the mechanisms and risks of congenital and acquired long QT syndrome, emphasizing the role of medications and underlying patient vulnerabilities.
Cite This Study
A. John Camm (2000) studied this question.